BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Karyopharm to Participate at Upcoming September 2023 Investor Conferences

  Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company’s senior management team will participate in the following investor conferences in September.

  September 5, 2023

   · 

  1 min read
• Genetown

  GENFIT to Participate in Upcoming September 2023 Investor Conferences

  GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, announced that it will participate in the following upcoming investor conferences.

  September 5, 2023

   · 

  4 min read
• Business

  NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer

  NANOBIOTIX announced the appointment of Louis Kayitalire, MD, as chief medical officer.

  September 5, 2023

   · 

  8 min read
• Biotech Beach

  Maravai LifeSciences to Host 2023 Investor R&D Day

  Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, starting at 10 a.m. ET in New York City.

  September 5, 2023

   · 

  1 min read
• Nyxoah to Participate in Upcoming September 2023 Investor Conferences

  Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced that the Company will participate in two upcoming investor conferences in New York City.

  September 5, 2023

   · 

  2 min read
• BioForest

  Alpine Immune Sciences to Participate in Two Upcoming September 2023 Healthcare Conferences

  Alpine Immune Sciences, Inc., a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced that the Company will participate in two upcoming healthcare conferences.

  September 5, 2023

   · 

  1 min read
• TCB Capital Advisors Welcomes Industry Veteran Nishant Sachdev to Further Strengthen Healthcare Platform

  TCB Capital Advisors (“TCB” or the “Company”) is thrilled to announce the appointment of Nishant Sachdev as Director, further solidifying its position as a leading healthcare-focused

  September 5, 2023

   · 

  2 min read
• Pharm Country

  Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

  Carmell Corporation, a regenerative care company, announced the completion of post-merger integration with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company.

  September 5, 2023

   · 

  4 min read
• Biotech Bay

  CytomX Therapeutics to Present at Upcoming September 2023 Investor Conferences

  CytomX Therapeutics, Inc., a leader in the field of conditionally activated, localized biologics, announced that management will participate in the following investor conferences in September.

  September 5, 2023

   · 

  2 min read
• Biotech Beach

  ResMed Announces Participation in Upcoming Conferences

  ResMed announced its participation in two upcoming conferences.

  September 5, 2023

   · 

  1 min read